speb/financial-data huggingface dataset:
Financial ratios for KNG.V — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -121223.74100719426
Net income: -111678.41726618705
Capital expenditures: 584523.7410071943
Operating cash flow: 4116.546762589928
Net tangible assets: 1707364.0287769786
Owner earnings: -696202.1582733813
Return on net tangible assets (%): -40.77643352789187
Buffett classification: The Gruesome
Stock price: 1.1366906474820144
Shares outstanding: 34523086
Book value: 1707364.0287769786
P/B ratio: 22.98400828236214
Market cap (USD): 39242068.97841727
Debt to equity: 0
Current ratio: 4.188548736649493
Quick ratio: 4.188548736649493
Free cash flow (dilution-adjusted): -580407.1942446043
Buyback yield (%): 0
Retained earnings: -2781496.402877698
Receivables turnover: 0
Capitalized R&D asset: 37722.06085821966
ROCI (R&D-adjusted, %): -7.005781838300659
Rule of 40 score: 0
Financial ratios for KNG.V — annual report dated 2025-12-31
Total revenue: 0
Operating income: -594549.6350364963
Net income: -581632.8467153284
Capital expenditures: 1018805.8394160583
Operating cash flow: -549081.7518248175
Net tangible assets: 4462884.671532846
Owner earnings: -1600438.6861313866
Return on net tangible assets (%): -35.861080980649476
Buffett classification: The Gruesome
Stock price: 1.656934306569343
Shares outstanding: 34523086
Book value: 4462884.671532846
P/B ratio: 12.817379289883537
Market cap (USD): 57202485.56204379
Debt to equity: 0
Current ratio: 19.52541419193498
Quick ratio: 19.52541419193498
Free cash flow (dilution-adjusted): -1567887.591240876
Buyback yield (%): 0
Retained earnings: -2999448.1751824813
Receivables turnover: 0
Capitalized R&D asset: 45180.29720279721
ROCI (R&D-adjusted, %): -13.857718251274765
Rule of 40 score: 0
Financial ratios for KNG.V — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -182651.82481751824
Net income: -177345.98540145985
Capital expenditures: 166543.06569343063
Operating cash flow: -230670.0729927007
Net tangible assets: 4462884.671532846
Owner earnings: -343889.05109489046
Return on net tangible assets (%): -7.705532999506719
Buffett classification: The Gruesome
Stock price: 1.656934306569343
Shares outstanding: 34523086
Book value: 4462884.671532846
P/B ratio: 12.817379289883537
Market cap (USD): 57202485.56204379
Debt to equity: 0
Current ratio: 19.52541419193498
Quick ratio: 19.52541419193498
Free cash flow (dilution-adjusted): -397213.13868613134
Buyback yield (%): 0
Retained earnings: -2999448.1751824813
Receivables turnover: 0
Capitalized R&D asset: 19685.500078769102
ROCI (R&D-adjusted, %): -4.388592776983469
Rule of 40 score: 0
Financial ratios for MED — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 188.97
Shares outstanding: 11119115
Market cap (USD): 2101179161.55
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MED — annual report dated 2022-12-31
Total revenue: 1598577000
Gross profit: 1140414000
Operating income: 184806000
Net income: 143568000
Capital expenditures: 16681000
Operating cash flow: 194570000
Depreciation & amortization: 10980000
Net tangible assets: 155044000
Owner earnings: 137867000
Return on net tangible assets (%): 88.92120946312015
Capex to operating income (%): 9.02622209235631
Buffett classification: The Great
Stock price: 109.01
P/E ratio: 8.442652444486237
Shares outstanding: 11119115
Book value: 155044000
P/B ratio: 7.817746743827559
Market cap (USD): 1212094726.15
Debt to equity: 0.1680232708134465
Current ratio: 1.5812170851846068
Quick ratio: 0.7376325464533621
Effective tax rate (%): 21.998924257982495
Interest coverage ratio: 263.63195435092723
COGS to revenue (%): 28.660677590131723
SG&A to revenue (%): 59.77866565076315
Free cash flow (dilution-adjusted): 166836000
Buyback yield (%): 10.557013180516426
Retained earnings: 139852000
Inventory turnover: 3.854773843979269
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 105.41127886880486
FCF margin (%): 10.436531990639175
Rule of 40 score: 10.436531990639175
Financial ratios for MED — annual report dated 2023-12-31
Total revenue: 1072054000
Gross profit: 775850000
Operating income: 126402000
Net income: 99415000
Capital expenditures: 6483000
Operating cash flow: 147657000
Depreciation & amortization: 13107000
Net tangible assets: 201481000
Owner earnings: 106039000
Return on net tangible assets (%): 52.62977650498062
Capex to operating income (%): 5.128874543124318
Buffett classification: The Great
Stock price: 67.22
P/E ratio: 7.518250870592969
Shares outstanding: 11119115
Book value: 201481000
P/B ratio: 3.7096644859813086
Market cap (USD): 747426910.3
Debt to equity: 0.10925099637186633
Current ratio: 2.4271830985915495
Quick ratio: 1.8357313109425786
Effective tax rate (%): 22.8126431516262
COGS to revenue (%): 27.62957836079153
SG&A to revenue (%): 60.57978422728706
Free cash flow (dilution-adjusted): 132986000
Buyback yield (%): 0.9311947300915906
Retained earnings: 174649000
Inventory turnover: 5.425876060156436
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 58.08701885960075
FCF margin (%): 12.404785579830866
Revenue growth (%): -32.9369808273233
Rule of 40 score: -20.53219524749244
Financial ratios for MED — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 19.14
Shares outstanding: 11119115
Market cap (USD): 212819861.1
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MED — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 17.62
Shares outstanding: 11119115
Market cap (USD): 195918806.3
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MED — annual report dated 2024-12-31
Total revenue: 602463000
Gross profit: 444623000
Operating income: 2878000
Net income: 2091000
Capital expenditures: 7454000
Operating cash flow: 24476000
Depreciation & amortization: 12707000
Net tangible assets: 210109000
Owner earnings: 7344000
Return on net tangible assets (%): 3.495328615147376
Capex to operating income (%): 258.99930507296733
Buffett classification: The Gruesome
Stock price: 17.62
P/E ratio: 93.696224916308
Shares outstanding: 11119115
Book value: 210109000
P/B ratio: 0.9324627041202423
Market cap (USD): 195918806.3
Debt to equity: 0.07674587951967789
Current ratio: 3.341656146257072
Quick ratio: 2.6804912641635883
Effective tax rate (%): 44.78479007129654
COGS to revenue (%): 26.199119282014
SG&A to revenue (%): 73.32317503315556
Free cash flow (dilution-adjusted): 9659000
Buyback yield (%): 0.4267073772998993
Retained earnings: 176782000
Inventory turnover: 3.7207986610405226
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.3078726846381763
FCF margin (%): 1.6032519839392627
Revenue growth (%): -43.802924106434936
Rule of 40 score: -42.19967212249567
Financial ratios for MED — quarterly report dated 2025-03-31
Total revenue: 115728000
Gross profit: 84245000
Operating income: -1262000
Net income: -772000
Capital expenditures: 1522000
Operating cash flow: 3406000
Depreciation & amortization: 3280000
Net tangible assets: 210959000
Owner earnings: 986000
Buffett classification: The Gruesome
Stock price: 13.48
Shares outstanding: 11119115
Book value: 210959000
P/B ratio: 0.7104966851378705
Market cap (USD): 149885670.20000002
Debt to equity: 0.06925516332557512
Current ratio: 3.5235981385524275
Quick ratio: 2.8740057427637877
Effective tax rate (%): 246.7680608365019
COGS to revenue (%): 27.204306650076038
SG&A to revenue (%): 73.88618139084751
Free cash flow (dilution-adjusted): -46000
Buyback yield (%): 0.24618764389392572
Retained earnings: 176012000
Inventory turnover: 0.7997916878366019
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.5751710245062963
FCF margin (%): -0.03974837550117517
Rule of 40 score: -0.03974837550117517
Financial ratios for MED — quarterly report dated 2025-06-30
Total revenue: 105555000
Gross profit: 76644000
Operating income: -1066000
Net income: 2480000
Capital expenditures: 1378000
Operating cash flow: -3378000
Depreciation & amortization: 4045000
Net tangible assets: 216005000
Owner earnings: 5147000
Return on net tangible assets (%): 2.382815212610819
Buffett classification: The Gruesome
Stock price: 14.05
P/E ratio: 91.46578790983608
Shares outstanding: 11119115
Book value: 216005000
P/B ratio: 0.7232405071641861
Market cap (USD): 156223565.75
Debt to equity: 0.06049859956945441
Current ratio: 4.469967954269877
Quick ratio: 3.816040187077776
Effective tax rate (%): 13.73913043478261
COGS to revenue (%): 27.389512576381982
SG&A to revenue (%): 73.62038747572356
Free cash flow (dilution-adjusted): -7383000
Buyback yield (%): 0.0006401082930089247
Retained earnings: 178492000
Inventory turnover: 0.9572861825767359
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.47770771995393213
FCF margin (%): -6.994457865567713
Revenue growth (%): -8.790439651596847
Rule of 40 score: -15.78489751716456
Financial ratios for MED — quarterly report dated 2025-09-30
Total revenue: 89409000
Gross profit: 62159000
Operating income: -4081000
Net income: -2261000
Capital expenditures: 1363000
Operating cash flow: 12113000
Depreciation & amortization: 3452000
Net tangible assets: 214706000
Owner earnings: -172000
Return on net tangible assets (%): -0.08010954514545472
Buffett classification: The Gruesome
Stock price: 13.67
Shares outstanding: 11119115
Book value: 214706000
P/B ratio: 0.7079369093085429
Market cap (USD): 151998302.05
Debt to equity: 0.05710599610630351
Current ratio: 4.4492539550018195
Quick ratio: 3.9524971635304946
COGS to revenue (%): 30.477916093458152
SG&A to revenue (%): 74.0865013589236
Free cash flow (dilution-adjusted): 9840000
Buyback yield (%): 0
Retained earnings: 176242000
Inventory turnover: 1.1743158801982332
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.8424711958680968
FCF margin (%): 11.00560346273865
Revenue growth (%): -15.296291033110702
Rule of 40 score: -4.290687570372052
Financial ratios for MED — annual report dated 2025-12-31
Total revenue: 385788000
Gross profit: 275187000
Operating income: -14213000
Net income: -18672000
Capital expenditures: 5614000
Operating cash flow: 6863000
Depreciation & amortization: 14242000
Net tangible assets: 198920000
Owner earnings: -10044000
Return on net tangible assets (%): -5.049266036597627
Buffett classification: The Gruesome
Stock price: 10.68
Shares outstanding: 11119115
Book value: 198920000
P/B ratio: 0.5969844570681682
Market cap (USD): 118752148.2
Debt to equity: 0.05376030565051277
Current ratio: 4.694450910106606
Quick ratio: 4.223616218984219
COGS to revenue (%): 28.668854396715293
SG&A to revenue (%): 75.01529337356268
Free cash flow (dilution-adjusted): -6390000
Buyback yield (%): 0.31073122094476774
Retained earnings: 158269000
Inventory turnover: 5.467718014633181
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -6.932798727873138
FCF margin (%): -1.6563501197548913
Revenue growth (%): -35.9648642323263
Rule of 40 score: -37.62121435208119
Financial ratios for MED — quarterly report dated 2025-12-31
Total revenue: 75096000
Gross profit: 52140000
Operating income: -7803000
Net income: -18119000
Capital expenditures: 1351000
Operating cash flow: -5278000
Depreciation & amortization: 3465000
Net tangible assets: 198920000
Owner earnings: -16005000
Return on net tangible assets (%): -8.045948119847175
Buffett classification: The Gruesome
Stock price: 10.68
Shares outstanding: 11119115
Book value: 198920000
P/B ratio: 0.5969844570681682
Market cap (USD): 118752148.2
Debt to equity: 0.05376030565051277
Current ratio: 4.694450910106606
Quick ratio: 4.223616218984219
COGS to revenue (%): 30.56887184403963
SG&A to revenue (%): 79.82182806008309
Free cash flow (dilution-adjusted): -8801000
Buyback yield (%): 0.000842090029660617
Retained earnings: 158269000
Inventory turnover: 1.1348625667391734
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3.8061372316607405
FCF margin (%): -11.71966549483328
Revenue growth (%): -16.008455524611616
Rule of 40 score: -27.728121019444895
Financial ratios for MINDTECK.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.3298166952393513
Shares outstanding: 31954221
Market cap (USD): 42493256.56916788
Buyback yield (%): 0
Retained earnings: 3252011.077409996
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MINDTECK.NS — annual report dated 2023-03-31
Total revenue: 41014616.32155908
Gross profit: 7591961.02314251
Operating income: 2781973.203410475
Net income: 2529841.6565164435
Capital expenditures: 165651.6443361754
Operating cash flow: 1549330.0852618758
Depreciation & amortization: 551766.1388550549
Net tangible assets: 19790499.390986603
Owner earnings: 2915956.151035323
Return on net tangible assets (%): 14.734121122599703
Capex to operating income (%): 5.954465849387041
Buffett classification: The Great
Stock price: 0.9931790499390988
P/E ratio: 12.544762543765048
Shares outstanding: 31954221
Book value: 23220462.85018271
P/B ratio: 1.36673687596517
Market cap (USD): 31736262.854323998
Debt to equity: 0.029532102391942927
Current ratio: 4.218985976267529
Quick ratio: 4.218985976267529
Effective tax rate (%): 20.053887605850655
Interest coverage ratio: 22.613861386138613
COGS to revenue (%): 81.48962076441066
SG&A to revenue (%): 2.360942001009711
Free cash flow (dilution-adjusted): 1373934.2265529842
Buyback yield (%): 2.7479832466766867
Retained earnings: 4928136.419001218
Receivables turnover: 5.03785158587672
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.630512272125468
FCF margin (%): 3.3498648769043444
Rule of 40 score: 3.3498648769043444
Financial ratios for MINDTECK.NS — annual report dated 2024-03-31
Total revenue: 46232162.12975177
Gross profit: 8965103.729463965
Operating income: 3468041.7316224966
Net income: 3274973.0183475236
Capital expenditures: 164288.2839669025
Operating cash flow: 2695766.8785226047
Depreciation & amortization: 537234.6804173163
Net tangible assets: 23109485.54982612
Owner earnings: 3647919.4147979375
Return on net tangible assets (%): 15.785376991334129
Capex to operating income (%): 4.737206085753804
Buffett classification: The Great
Stock price: 1.9376199616122842
P/E ratio: 18.905540937436914
Shares outstanding: 31954221
Book value: 26491185.993524402
P/B ratio: 2.337197605365996
Market cap (USD): 61915136.46737044
Debt to equity: 0.010004074057308406
Current ratio: 4.653081710499899
Quick ratio: 4.653081710499899
Effective tax rate (%): 18.550551744706233
Interest coverage ratio: 32.49438202247191
COGS to revenue (%): 80.60851295619018
SG&A to revenue (%): 1.9609368920706558
Free cash flow (dilution-adjusted): 2399568.2935603787
Buyback yield (%): 0
Retained earnings: 7855858.016548747
Receivables turnover: 5.187432723358451
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.812333864965444
FCF margin (%): 5.1902575675044735
Revenue growth (%): 12.72118643579782
Rule of 40 score: 17.911444003302293
Financial ratios for MINDTECK.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 25799092.21213569
Buffett classification: The Gruesome
Stock price: 3.4136407071189683
Shares outstanding: 31954221
Book value: 29167462.971810795
P/B ratio: 3.73979148187477
Market cap (USD): 109080229.56987579
Debt to equity: 0.001310454973586142
Current ratio: 5.128375654977831
Quick ratio: 5.128375654977831
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MINDTECK.NS — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.4421261219256323
Shares outstanding: 31954221
Market cap (USD): 109990458.8098846
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MINDTECK.NS — quarterly report dated 2025-03-31
Total revenue: 12160392.79869067
Gross profit: 2395370.5868599485
Operating income: 865092.3544540565
Net income: 794949.7311199438
Capital expenditures: 0
Depreciation & amortization: 136778.11550151976
Net tangible assets: 27086743.04418985
Owner earnings: 931727.8466214635
Return on net tangible assets (%): 3.439792835563228
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.9358151476251604
P/E ratio: 19.453263087219288
Shares outstanding: 31954221
Book value: 30382277.297170915
P/B ratio: 2.03597197265137
Market cap (USD): 61857465.042362
Debt to equity: 0.028627496248412786
Current ratio: 4.684965100924353
Quick ratio: 4.684965100924353
Effective tax rate (%): 24.778761061946902
Interest coverage ratio: 20.555555555555557
COGS to revenue (%): 80.30186502595656
Buyback yield (%): 0
Retained earnings: 10667523.965396306
Receivables turnover: 1.195082720588235
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.754410779423807
Rule of 40 score: 0
Financial ratios for MINDTECK.NS — annual report dated 2025-03-31
Total revenue: 49616553.65910685
Gross profit: 11692775.309796585
Operating income: 3643909.282207154
Net income: 3352817.395370587
Capital expenditures: 81833.0605564648
Operating cash flow: 2820902.5017535654
Depreciation & amortization: 547112.462006079
Net tangible assets: 27086743.04418985
Owner earnings: 3818096.796820201
Return on net tangible assets (%): 14.095813552006906
Capex to operating income (%): 2.245749117741418
Buffett classification: The Great
Stock price: 1.9358151476251604
P/E ratio: 18.449398743806295
Shares outstanding: 31954221
Book value: 30382277.297170915
P/B ratio: 2.03597197265137
Market cap (USD): 61857465.042362
Debt to equity: 0.028627496248412786
Current ratio: 4.684965100924353
Quick ratio: 4.684965100924353
Effective tax rate (%): 18.730518560498723
Interest coverage ratio: 28.336363636363636
COGS to revenue (%): 76.43372131379293
SG&A to revenue (%): 2.00980161161114
Free cash flow (dilution-adjusted): 2545008.1833060556
Buyback yield (%): 0
Retained earnings: 10667523.965396306
Receivables turnover: 4.876148897058823
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.60202486414055
FCF margin (%): 5.129352999387399
Revenue growth (%): 7.320426675820818
Rule of 40 score: 12.449779675208218
Financial ratios for MINDTECK.NS — quarterly report dated 2025-06-30
Total revenue: 11853498.712848118
Gross profit: 2203369.997659724
Operating income: 988766.6744675873
Net income: 1023870.8167563773
Capital expenditures: 0
Depreciation & amortization: 136906.1549262813
Owner earnings: 1160776.9716826587
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.7678446056634685
P/E ratio: 48.62729219014876
Shares outstanding: 31954221
Market cap (USD): 88444318.22302832
Effective tax rate (%): 18.680297397769515
Interest coverage ratio: 24.852941176470587
COGS to revenue (%): 81.4116485686081
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -2.5237185255693015
Rule of 40 score: -2.5237185255693015
Financial ratios for MINDTECK.NS — quarterly report dated 2025-09-30
Total revenue: 11457722.66065389
Gross profit: 1825253.6640360765
Operating income: 683201.8038331454
Net income: 852311.1612175873
Capital expenditures: 0
Depreciation & amortization: 129650.50732807216
Net tangible assets: 28432919.95490417
Owner earnings: 981961.6685456594
Return on net tangible assets (%): 3.45360824742268
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.567531003382187
P/E ratio: 30.714866222099033
Shares outstanding: 31954221
Book value: 31609921.082299884
P/B ratio: 2.5954969293601544
Market cap (USD): 82043453.10642616
Debt to equity: 0.020400884513874028
Current ratio: 5.403241366004244
Quick ratio: 5.403241366004244
Effective tax rate (%): 22.778345250255363
Interest coverage ratio: 20.896551724137932
COGS to revenue (%): 84.0696644691528
Buyback yield (%): 0
Receivables turnover: 0.9575089504428114
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.107166452241038
Revenue growth (%): -3.338896487711624
Rule of 40 score: -3.338896487711624
Financial ratios for MINDTECK.NS — quarterly report dated 2025-12-31
Total revenue: 11190820.986966694
Gross profit: 1932716.9432995433
Operating income: 1037094.7978166426
Net income: 562548.7356577922
Capital expenditures: 0
Depreciation & amortization: 126991.19973265012
Owner earnings: 689539.9353904423
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.274479224685307
P/E ratio: 22.475693887273902
Shares outstanding: 31954221
Market cap (USD): 72679211.80550297
Effective tax rate (%): 15.55183946488294
Interest coverage ratio: 37.239999999999995
COGS to revenue (%): 82.72944455504678
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -2.329447845720184
Rule of 40 score: -2.329447845720184
Financial ratios for MTVA — annual report dated 2021-12-31
Capital expenditures: 3000
Buffett classification: The Gruesome
Stock price: 3220.8
Shares outstanding: 5164370
Market cap (USD): 16633402896
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MTVA — annual report dated 2022-12-31
Total revenue: 0
Operating income: -11418000
Net income: -13967000
Capital expenditures: 8000
Operating cash flow: -11712000
Depreciation & amortization: 20000
Net tangible assets: 21750000
Owner earnings: -13955000
Return on net tangible assets (%): -64.16091954022988
Buffett classification: The Gruesome
Stock price: 63.18
Shares outstanding: 5164370
Book value: 21750000
P/B ratio: 15.00160444137931
Market cap (USD): 326284896.6
Debt to equity: 0
Current ratio: 2.845553292600136
Quick ratio: 2.845553292600136
Interest coverage ratio: -5.211319032405294
Free cash flow (dilution-adjusted): -12566000
Buyback yield (%): 0
Retained earnings: -95795000
Capitalized R&D asset: 2778000
ROCI (R&D-adjusted, %): -39.00032615786041
Rule of 40 score: 0
Financial ratios for MTVA — annual report dated 2023-12-31
Total revenue: 0
Operating income: -15886000
Net income: -12470000
Capital expenditures: 50000
Operating cash flow: -10799000
Depreciation & amortization: 6000
Net tangible assets: 16685000
Owner earnings: -12514000
Return on net tangible assets (%): -75.001498351813
Buffett classification: The Gruesome
Stock price: 40.67
Shares outstanding: 5164370
Book value: 16685000
P/B ratio: 12.588248600539407
Market cap (USD): 210034927.9
Debt to equity: 0.012166616721606233
Current ratio: 3.7771812080536913
Quick ratio: 3.7771812080536913
Free cash flow (dilution-adjusted): -11071000
Buyback yield (%): 0
Retained earnings: -108265000
Capitalized R&D asset: 11019260
ROCI (R&D-adjusted, %): -38.45749524848786
Rule of 40 score: 0
Financial ratios for MTVA — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 34.87
Shares outstanding: 5164370
Market cap (USD): 180081581.89999998
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MTVA — annual report dated 2024-12-31
Total revenue: 0
Operating income: -28809000
Net income: -27592000
Capital expenditures: 8000
Operating cash flow: -24710000
Depreciation & amortization: 20000
Net tangible assets: 7931000
Owner earnings: -27580000
Return on net tangible assets (%): -347.74933804060015
Buffett classification: The Gruesome
Stock price: 22.33
Shares outstanding: 5164370
Book value: 7931000
P/B ratio: 14.54045922330097
Market cap (USD): 115320382.1
Debt to equity: 0.017147900643046273
Current ratio: 1.943174948615645
Quick ratio: 1.943174948615645
Free cash flow (dilution-adjusted): -25256000
Buyback yield (%): 0
Retained earnings: -135857000
Capitalized R&D asset: 28605600
ROCI (R&D-adjusted, %): -50.332562727834166
Rule of 40 score: 0
Financial ratios for MTVA — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 22.33
Shares outstanding: 5164370
Market cap (USD): 115320382.1
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MTVA — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -3886000
Net income: -3671000
Capital expenditures: 0
Operating cash flow: -4815000
Depreciation & amortization: 4000
Net tangible assets: 4380000
Owner earnings: -3667000
Return on net tangible assets (%): -83.7214611872146
Buffett classification: The Gruesome
Stock price: 16.94
Shares outstanding: 5164370
Book value: 4380000
P/B ratio: 19.973613652968037
Market cap (USD): 87484427.80000001
Debt to equity: 0.026940639269406392
Current ratio: 1.5513618677042802
Quick ratio: 1.5513618677042802
Free cash flow (dilution-adjusted): -4947000
Buyback yield (%): 0
Retained earnings: -139528000
Capitalized R&D asset: 2327000
ROCI (R&D-adjusted, %): -34.61842625543693
Rule of 40 score: 0
Financial ratios for MTVA — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -4301000
Net income: -3995000
Capital expenditures: 2000
Operating cash flow: -3071000
Depreciation & amortization: 5000
Net tangible assets: 9624000
Owner earnings: -3992000
Return on net tangible assets (%): -41.479634247714046
Buffett classification: The Gruesome
Stock price: 7.07
Shares outstanding: 5164370
Book value: 9624000
P/B ratio: 3.7938586762261015
Market cap (USD): 36512095.9
Debt to equity: 0.010182876142975894
Current ratio: 2.076530612244898
Quick ratio: 2.076530612244898
Free cash flow (dilution-adjusted): -3184000
Buyback yield (%): 0
Retained earnings: -143523000
Capitalized R&D asset: 3879090
ROCI (R&D-adjusted, %): -26.113156518413472
Rule of 40 score: 0
Financial ratios for MTVA — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -3475000
Net income: -3377000
Capital expenditures: 0
Operating cash flow: -2955000
Depreciation & amortization: 5000
Net tangible assets: 6331000
Owner earnings: -3372000
Return on net tangible assets (%): -53.2617280050545
Buffett classification: The Gruesome
Stock price: 10.34
Shares outstanding: 5164370
Book value: 6331000
P/B ratio: 8.43462103933028
Market cap (USD): 53399585.8
Debt to equity: 0.012478281472121308
Current ratio: 1.7365425658050746
Quick ratio: 1.7365425658050746
Free cash flow (dilution-adjusted): -3052000
Buyback yield (%): 0
Retained earnings: -146900000
Capitalized R&D asset: 4236310
ROCI (R&D-adjusted, %): -35.46787214532364
Rule of 40 score: 0
Financial ratios for MTVA — annual report dated 2025-12-31
Total revenue: 0
Operating income: -13708000
Net income: -12973000
Capital expenditures: 2000
Operating cash flow: -15701000
Depreciation & amortization: 19000
Net tangible assets: 5333000
Owner earnings: -12956000
Return on net tangible assets (%): -242.94018376148506
Buffett classification: The Gruesome
Stock price: 8.42
Shares outstanding: 5164370
Book value: 5333000
P/B ratio: 8.153758747421714
Market cap (USD): 43483995.4
Debt to equity: 0.039377461091318205
Current ratio: 1.9254603399433428
Quick ratio: 1.9254603399433428
Free cash flow (dilution-adjusted): -16114000
Buyback yield (%): 0
Retained earnings: -148830000
Capitalized R&D asset: 24264650
ROCI (R&D-adjusted, %): -65.26752444407832
Rule of 40 score: 0
Financial ratios for MTVA — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -2046000
Net income: -1930000
Capital expenditures: 0
Operating cash flow: -4860000
Depreciation & amortization: 5000
Net tangible assets: 5333000
Owner earnings: -1925000
Return on net tangible assets (%): -36.09600600037503
Buffett classification: The Gruesome
Stock price: 8.42
Shares outstanding: 5164370
Book value: 5333000
P/B ratio: 8.153758747421714
Market cap (USD): 43483995.4
Debt to equity: 0.039377461091318205
Current ratio: 1.9254603399433428
Quick ratio: 1.9254603399433428
Free cash flow (dilution-adjusted): -4931000
Buyback yield (%): 0
Retained earnings: -148830000
Capitalized R&D asset: 2288980
ROCI (R&D-adjusted, %): -42.461040170977604
Rule of 40 score: 0
Financial ratios for ODA.AX — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.09022556390977443
Shares outstanding: 187514212
Market cap (USD): 16918575.51879699
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ODA.AX — annual report dated 2022-06-30
Total revenue: 11083928.27586207
Gross profit: 6314538.620689656
Operating income: -183623.4482758621
Net income: -277072.4137931035
Capital expenditures: 401505.5172413793
Depreciation & amortization: 439386.2068965517
Net tangible assets: 3812360
Owner earnings: -239191.72413793107
Return on net tangible assets (%): -6.274111682473089
Buffett classification: The Gruesome
Stock price: 0.048275862068965524
Shares outstanding: 187514212
Book value: 9787028.965517242
P/B ratio: 0.9249395568744332
Market cap (USD): 9052410.23448276
Debt to equity: 0.15653674476393528
Current ratio: 1.603362995201095
Quick ratio: 1.603362995201095
Effective tax rate (%): 0
Interest coverage ratio: -3.6899772714673764
COGS to revenue (%): 43.029777317838764
SG&A to revenue (%): 33.26423048320476
Free cash flow (dilution-adjusted): 337677.9310344828
Buyback yield (%): 0.13241662983923586
Retained earnings: -60393755.862068966
Receivables turnover: 5.116749872731493
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.678871643694373
FCF margin (%): 3.046554638664146
Rule of 40 score: 3.046554638664146
Financial ratios for ODA.AX — annual report dated 2023-06-30
Total revenue: 13186588.741721854
Gross profit: 7601484.105960265
Operating income: -143693.3774834437
Net income: 261887.41721854304
Capital expenditures: 55293.377483443706
Depreciation & amortization: 583247.6821192052
Net tangible assets: 4406831.78807947
Owner earnings: 789841.7218543045
Return on net tangible assets (%): 17.923119370946612
Buffett classification: The Gruesome
Stock price: 0.17880794701986755
P/E ratio: 128.02841633581997
Shares outstanding: 187514212
Book value: 10509249.66887417
P/B ratio: 3.1904305579562933
Market cap (USD): 33529031.284768213
Debt to equity: 0.2622066704152829
Current ratio: 2.03771088742494
Quick ratio: 2.03771088742494
Effective tax rate (%): 0
Interest coverage ratio: -1.020069767004532
COGS to revenue (%): 42.354431044706324
SG&A to revenue (%): 36.51277946502841
Free cash flow (dilution-adjusted): 1168332.4503311259
Buyback yield (%): 0.12159275890176457
Retained earnings: -57588076.821192056
Receivables turnover: 10.606690417316099
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.151460915671914
FCF margin (%): 8.860005216015931
Revenue growth (%): 18.970354314172482
Rule of 40 score: 27.830359530188414
Financial ratios for ODA.AX — annual report dated 2024-06-30
Total revenue: 16713390.666666666
Gross profit: 10586840
Operating income: 691285.3333333334
Net income: 603537.3333333334
Capital expenditures: 227156
Depreciation & amortization: 804217.3333333334
Net tangible assets: 4301187.333333333
Owner earnings: 1180598.6666666667
Return on net tangible assets (%): 27.44820383704903
Capex to operating income (%): 32.859947845944944
Buffett classification: The Good
Stock price: 0.11333333333333334
P/E ratio: 35.211758278416355
Shares outstanding: 187514212
Book value: 11520476
P/B ratio: 1.84468165146417
Market cap (USD): 21251610.693333335
Debt to equity: 0.2446570205374616
Current ratio: 1.5654916149116427
Quick ratio: 1.5107763115710804
Effective tax rate (%): -1.63526955115971
Interest coverage ratio: 3.12576265464104
COGS to revenue (%): 36.65653959064999
SG&A to revenue (%): 39.95941617432026
Free cash flow (dilution-adjusted): 827891.3333333334
Buyback yield (%): 0.012777070747795778
Retained earnings: -57368460
Inventory turnover: 35.63647010008648
Receivables turnover: 9.570543289667322
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.151468918910796
FCF margin (%): 4.9534612685413215
Revenue growth (%): 26.74536981491012
Rule of 40 score: 31.69883108345144
Financial ratios for OEWA.DE — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 92.60227272727272
Shares outstanding: 170233686
Market cap (USD): 15764026218.340908
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for OEWA.DE — annual report dated 2022-12-31
Total revenue: 11006463829.787235
Gross profit: 3148919148.9361706
Operating income: 1943551063.8297873
Net income: 2073156382.9787235
Capital expenditures: 1160879787.2340426
Operating cash flow: 2148786170.212766
Depreciation & amortization: 568598936.1702127
Net tangible assets: 6416155319.148936
Owner earnings: 1480875531.9148936
Return on net tangible assets (%): 23.0804190087986
Capex to operating income (%): 59.72983210158199
Buffett classification: The Good
Stock price: 69.02127659574468
P/E ratio: 5.667563925128042
Shares outstanding: 170233686
Book value: 8854275531.914892
P/B ratio: 1.3270138573130739
Market cap (USD): 11749746327.319149
Debt to equity: 0.4633174572832287
Current ratio: 0.9436543204039358
Quick ratio: 0.913982956092894
Effective tax rate (%): 23.03809576090223
Interest coverage ratio: 17.981673228346455
COGS to revenue (%): 71.39027395507243
SG&A to revenue (%): 0.7461766180723977
Free cash flow (dilution-adjusted): 987906382.9787234
Buyback yield (%): 0
Retained earnings: 7771276595.744681
Inventory turnover: 60.04952845528456
Receivables turnover: 10.684783641433441
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.17047260541489
FCF margin (%): 8.975692813391278
Rule of 40 score: 8.975692813391278
Financial ratios for OEWA.DE — annual report dated 2023-12-31
Total revenue: 11610537777.777777
Gross profit: 5226956666.666667
Operating income: 3787092222.2222223
Net income: 3035700000
Capital expenditures: 1553911111.1111112
Operating cash flow: 5647743333.333333
Depreciation & amortization: 1098351111.1111112
Net tangible assets: 9965468888.88889
Owner earnings: 2580140000
Return on net tangible assets (%): 25.89080382235457
Capex to operating income (%): 41.03177371791844
Buffett classification: The Good
Stock price: 80.52222222222223
P/E ratio: 4.515464207200975
Shares outstanding: 170233686
Book value: 12467678888.88889
P/B ratio: 1.0994504122187585
Market cap (USD): 13707594693.800001
Debt to equity: 0.213930936623595
Current ratio: 1.1356642383330857
Quick ratio: 1.110105052051536
Effective tax rate (%): 23.199267335633312
Interest coverage ratio: 23.81819007686932
COGS to revenue (%): 54.98092537392277
SG&A to revenue (%): 0.6038575684694095
Free cash flow (dilution-adjusted): 4093832222.2222223
Buyback yield (%): 0
Retained earnings: 9247487777.777777
Inventory turnover: 71.10424504950495
Receivables turnover: 10.750497942386831
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 20.87954895440622
FCF margin (%): 35.259626216950046
Revenue growth (%): 5.488356272572412
Rule of 40 score: 40.74798248952246
Financial ratios for OEWA.DE — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 75.52222222222223
Shares outstanding: 170233686
Market cap (USD): 12856426263.800001
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for OEWA.DE — annual report dated 2024-12-31
Total revenue: 8588119791.666667
Gross profit: 4327268750
Operating income: 2822403125
Net income: 2228858333.3333335
Capital expenditures: 1184907291.6666667
Operating cash flow: 3383912500
Depreciation & amortization: 785756250
Net tangible assets: 9242064583.333334
Owner earnings: 1829707291.6666667
Return on net tangible assets (%): 19.797603394443566
Capex to operating income (%): 41.98221300037239
Buffett classification: The Good
Stock price: 67.23958333333333
P/E ratio: 5.135562877528853
Shares outstanding: 170233686
Book value: 11525865625
P/B ratio: 0.9931091067997333
Market cap (USD): 11446442115.9375
Debt to equity: 0.20773024007325555
Current ratio: 1.4084184651466976
Quick ratio: 1.3553097444918027
Effective tax rate (%): 22.982132630814345
Interest coverage ratio: 21.641429712460063
COGS to revenue (%): 49.61331636059746
SG&A to revenue (%): 0.8175052867969865
Free cash flow (dilution-adjusted): 2199005208.3333335
Buyback yield (%): 0
Retained earnings: 9124410416.666668
Inventory turnover: 43.42268577494693
Receivables turnover: 9.521417022750894
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 15.990394810945865
FCF margin (%): 25.605199527690566
Revenue growth (%): -26.031679530778735
Rule of 40 score: -0.42648000308816947
Financial ratios for OEWA.DE — quarterly report dated 2024-12-31
Total revenue: 2507286458.3333335
Gross profit: 1131852083.3333335
Operating income: 747507291.6666667
Net income: 593962500
Capital expenditures: 387615625
Operating cash flow: 953912500
Depreciation & amortization: 359818750
Net tangible assets: 9242064583.333334
Owner earnings: 566165625
Return on net tangible assets (%): 6.125964819819525
Capex to operating income (%): 51.85442728401478
Buffett classification: The Good
Stock price: 67.23958333333333
P/E ratio: 4.817830299024559
Shares outstanding: 170233686
Book value: 11525865625
P/B ratio: 0.9931091067997333
Market cap (USD): 11446442115.9375
Debt to equity: 0.20773024007325555
Current ratio: 1.4084184651466976
Quick ratio: 1.3553097444918027
Effective tax rate (%): 21.73112591691573
Interest coverage ratio: 52.00050724637682
COGS to revenue (%): 54.857488278953625
Free cash flow (dilution-adjusted): 566296875
Buyback yield (%): 0
Retained earnings: 9124410416.666668
Inventory turnover: 14.017165605095542
Receivables turnover: 2.779760942372098
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.235021075457059
FCF margin (%): 22.586046086510354
Rule of 40 score: 22.586046086510354
Financial ratios for OEWA.DE — quarterly report dated 2025-03-31
Total revenue: 2494565217.391304
Gross profit: 1077934782.6086955
Operating income: 650217391.3043478
Net income: 483913043.4782609
Capital expenditures: 266630434.7826087
Operating cash flow: 585217391.3043478
Depreciation & amortization: 161739130.4347826
Net tangible assets: 10116521739.130434
Owner earnings: 379021739.1304348
Return on net tangible assets (%): 3.746561801615954
Capex to operating income (%): 41.00635239050485
Buffett classification: The Good
Stock price: 65
P/E ratio: 5.716517533018868
Shares outstanding: 170233686
Book value: 12551521739.130436
P/B ratio: 0.881581518159932
Market cap (USD): 11065189590
Debt to equity: 0.015206886398669827
Current ratio: 1.509382703627308
Quick ratio: 1.4510237963475374
Effective tax rate (%): 22.761970853573906
Interest coverage ratio: 21.288256227758005
COGS to revenue (%): 56.78867102396515
Free cash flow (dilution-adjusted): 318586956.5217391
Buyback yield (%): 0
Retained earnings: 9950217391.304348
Inventory turnover: 11.235344827586207
Receivables turnover: 2.557388009806106
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.505584791551903
FCF margin (%): 12.77124183006536
Revenue growth (%): -0.5073708630200019
Rule of 40 score: 12.263870967045358
Financial ratios for OEWA.DE — quarterly report dated 2025-06-30
Total revenue: 2048705882.3529413
Gross profit: 1098588235.2941177
Operating income: 629882352.9411765
Net income: 538823529.4117647
Capital expenditures: 361764705.88235295
Operating cash flow: 941176470.5882354
Depreciation & amortization: 177882352.94117647
Net tangible assets: 10191058823.529411
Owner earnings: 354941176.4705883
Return on net tangible assets (%): 3.4828684891023283
Capex to operating income (%): 57.43369443406798
Buffett classification: The Good
Stock price: 72.27058823529411
P/E ratio: 7.6098816600974475
Shares outstanding: 170233686
Book value: 12534823529.411764
P/B ratio: 0.9814967554840164
Market cap (USD): 12302888624.682352
Debt to equity: 0.0165656148518011
Current ratio: 0.9844095592598587
Quick ratio: 0.9225333117548687
Effective tax rate (%): 21.909633418584825
Interest coverage ratio: 18.85211267605634
COGS to revenue (%): 46.37647869530263
Free cash flow (dilution-adjusted): 579411764.7058823
Buyback yield (%): 0
Retained earnings: 10103058823.529411
Inventory turnover: 7.040976460331299
Receivables turnover: 2.55712187958884
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.3180877303883296
FCF margin (%): 28.281842195934303
Revenue growth (%): -17.873228245546567
Rule of 40 score: 10.408613950387736
Financial ratios for OEWA.DE — annual report dated 2025-12-31
Total revenue: 9427712941.176472
Gross profit: 4357575294.117647
Operating income: 2494670588.2352943
Net income: 1992250588.235294
Capital expenditures: 1609787058.8235295
Operating cash flow: 2257111764.7058825
Depreciation & amortization: 735515294.117647
Net tangible assets: 10884717647.058825
Owner earnings: 1117978823.5294116
Return on net tangible assets (%): 10.271087039464936
Capex to operating income (%): 64.52904308950373
Buffett classification: The Good
Stock price: 69.29411764705883
P/E ratio: 5.921038816520246
Shares outstanding: 170233686
Book value: 13330827058.823532
P/B ratio: 0.8848808114548825
Market cap (USD): 11796193065.176472
Debt to equity: 0.20308523287421465
Current ratio: 0.977604536675645
Quick ratio: 0.9344456956722473
Effective tax rate (%): 19.973450708485192
Interest coverage ratio: 18.715533980582524
COGS to revenue (%): 53.779083842428996
SG&A to revenue (%): 0.8585451951667898
Free cash flow (dilution-adjusted): 647324705.882353
Buyback yield (%): 0
Retained earnings: 10919603529.411764
Inventory turnover: 56.70548684210526
Receivables turnover: 10.567791111697218
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.585314863452298
FCF margin (%): 6.8661902406372395
Revenue growth (%): 9.776216097084363
Rule of 40 score: 16.642406337721603
Financial ratios for OEWA.DE — quarterly report dated 2025-12-31
Total revenue: 2513830588.2352943
Gross profit: 991928235.2941177
Operating income: 522788235.2941177
Net income: 368132941.1764706
Capital expenditures: 566845882.3529412
Operating cash flow: 311464705.88235295
Depreciation & amortization: 226574117.6470588
Net tangible assets: 10884717647.058825
Owner earnings: 27861176.470588207
Return on net tangible assets (%): 0.25596600090142546
Capex to operating income (%): 108.42743659562974
Buffett classification: The Gruesome
Stock price: 69.29411764705883
P/E ratio: 5.94316948818686
Shares outstanding: 170233686
Book value: 13330827058.823532
P/B ratio: 0.8848808114548825
Market cap (USD): 11796193065.176472
Debt to equity: 0.20308523287421465
Current ratio: 0.977604536675645
Quick ratio: 0.9344456956722473
Effective tax rate (%): 21.959826817370136
Interest coverage ratio: 15.537412587412588
COGS to revenue (%): 60.54116614157161
Free cash flow (dilution-adjusted): -255381176.47058824
Buyback yield (%): 0
Retained earnings: 10919603529.411764
Inventory turnover: 17.02127631578947
Receivables turnover: 2.817824080179349
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.6374041443039977
FCF margin (%): -10.159044832446943
Revenue growth (%): 22.70334213850925
Rule of 40 score: 12.544297306062306
Financial ratios for RAL — quarterly report dated 2025-06-30
Total revenue: 503300000
Gross profit: 248300000
Operating income: 58900000
Net income: 47600000
Capital expenditures: 11600000
Operating cash flow: 85400000
Depreciation & amortization: 28600000
Net tangible assets: -918100000
Owner earnings: 64600000
Return on net tangible assets (%): -7.036270558762663
Capex to operating income (%): 19.69439728353141
Buffett classification: The Great
Stock price: 48.29
P/E ratio: 48.47759387372197
Shares outstanding: 111933148
Book value: 3039800000
P/B ratio: 1.778160312165274
Market cap (USD): 5405251716.92
Debt to equity: 0.3778209092703467
Current ratio: 1.5887096774193548
Quick ratio: 1.0271942985746436
Effective tax rate (%): 19.185059422750424
COGS to revenue (%): 50.66560699384065
R&D to revenue (%): 8.344923504867872
SG&A to revenue (%): 29.286707728988677
Free cash flow (dilution-adjusted): 65700000
Buyback yield (%): 0
Inventory turnover: 0.8517034068136272
Receivables turnover: 1.7397165572070514
Capitalized R&D asset: 69671000
ROCI (R&D-adjusted, %): 1.551581272767634
Rosenberg metric: 0.11864406779661017
FCF margin (%): 13.053844625471886
Revenue growth (%): 4.462432544624326
Rule of 40 score: 17.51627717009621
Financial ratios for RAL — quarterly report dated 2025-09-30
Total revenue: 529100000
Gross profit: 268600000
Operating income: 52000000
Net income: 39900000
Capital expenditures: 12000000
Operating cash flow: 138600000
Depreciation & amortization: 30000000
Net tangible assets: -963900000
Owner earnings: 57900000
Return on net tangible assets (%): -6.006847183317771
Capex to operating income (%): 23.076923076923077
Buffett classification: The Great
Stock price: 43.6
P/E ratio: 32.234380797886395
Shares outstanding: 111933148
Book value: 2964200000
P/B ratio: 1.6464088971054585
Market cap (USD): 4880285252.8
Debt to equity: 0.38749072262330475
Current ratio: 1.4878160219311605
Quick ratio: 1.026804751751447
Effective tax rate (%): -13.352272727272727
Interest coverage ratio: 3.1901840490797544
COGS to revenue (%): 49.234549234549235
R&D to revenue (%): 7.3332073332073335
SG&A to revenue (%): 33.6042336042336
Free cash flow (dilution-adjusted): 95300000
Buyback yield (%): 0
Retained earnings: 34300000
Inventory turnover: 0.8605880409646515
Receivables turnover: 1.7084275104940265
Capitalized R&D asset: 80569000
ROCI (R&D-adjusted, %): 1.0684423709695892
Rosenberg metric: 0.48333333333333334
FCF margin (%): 18.01171801171801
Revenue growth (%): 5.126167295847408
Rule of 40 score: 23.13788530756542
Financial ratios for RAL — annual report dated 2025-12-31
Total revenue: 2068800000
Gross profit: 1040300000
Operating income: 258700000
Net income: -1222500000
Capital expenditures: 37700000
Operating cash flow: 397600000
Depreciation & amortization: 115500000
Net tangible assets: -833300000
Owner earnings: -1144700000
Capex to operating income (%): 14.572864321608039
Buffett classification: The Great
Stock price: 50.81
Shares outstanding: 111933148
Book value: 1634300000
P/B ratio: 3.4799750657039716
Market cap (USD): 5687323249.88
Debt to equity: 0.7483326194701095
Current ratio: 0.8416831939294646
Quick ratio: 0.5816159351556437
Interest coverage ratio: 8.009287925696594
COGS to revenue (%): 49.71481051817479
R&D to revenue (%): 7.975638051044083
SG&A to revenue (%): 29.804717710750197
Free cash flow (dilution-adjusted): 302200000
Buyback yield (%): 0
Retained earnings: -1345300000
Inventory turnover: 3.4101458885941645
Receivables turnover: 7.251314405888539
Capitalized R&D asset: 327840000
ROCI (R&D-adjusted, %): 8.70867254900649
Rosenberg metric: -0.43914373088685016
FCF margin (%): 14.607501933488013
Revenue growth (%): -3.9866338701443356
Rule of 40 score: 10.620868063343679
Financial ratios for RAL — quarterly report dated 2025-12-31
Total revenue: 554500000
Gross profit: 279900000
Operating income: 73900000
Net income: -1373900000
Capital expenditures: 10000000
Operating cash flow: 101600000
Depreciation & amortization: 30000000
Net tangible assets: -833300000
Owner earnings: -1353900000
Capex to operating income (%): 13.531799729364005
Buffett classification: The Great
Stock price: 50.81
Shares outstanding: 111933148
Book value: 1634300000
P/B ratio: 3.4799750657039716
Market cap (USD): 5687323249.88
Debt to equity: 0.7483326194701095
Current ratio: 0.8416831939294646
Quick ratio: 0.5816159351556437
Interest coverage ratio: 4.61875
COGS to revenue (%): 49.52209197475203
R&D to revenue (%): 7.736699729486024
SG&A to revenue (%): 29.413886384129846
Free cash flow (dilution-adjusted): 81300000
Buyback yield (%): 0
Retained earnings: -1345300000
Inventory turnover: 0.9104774535809018
Receivables turnover: 1.9435681738520856
Capitalized R&D asset: 82756000
ROCI (R&D-adjusted, %): 2.7532290628285168
Rosenberg metric: 0.2912371134020619
FCF margin (%): 14.66185752930568
Revenue growth (%): 4.8006048006048
Rule of 40 score: 19.46246232991048
Financial ratios for RAMP — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 37.39
Shares outstanding: 60786315
Market cap (USD): 2272800317.85
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0